CDLX vs. RXT, VNET, DADA, TRMR, EB, NEXN, HCAT, TINV, DSP, and ADTH
Should you be buying Cardlytics stock or one of its competitors? The main competitors of Cardlytics include Rackspace Technology (RXT), VNET Group (VNET), Dada Nexus (DADA), Tremor International (TRMR), Eventbrite (EB), Nexxen International (NEXN), Health Catalyst (HCAT), Tiga Acquisition (TINV), Viant Technology (DSP), and AdTheorent (ADTH). These companies are all part of the "computer programming, data processing, & other computer related" industry.
Cardlytics (NASDAQ:CDLX) and Rackspace Technology (NASDAQ:RXT) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, community ranking, institutional ownership, profitability and dividends.
Cardlytics has higher earnings, but lower revenue than Rackspace Technology. Cardlytics is trading at a lower price-to-earnings ratio than Rackspace Technology, indicating that it is currently the more affordable of the two stocks.
In the previous week, Cardlytics had 3 more articles in the media than Rackspace Technology. MarketBeat recorded 7 mentions for Cardlytics and 4 mentions for Rackspace Technology. Cardlytics' average media sentiment score of 0.80 beat Rackspace Technology's score of 0.43 indicating that Cardlytics is being referred to more favorably in the media.
Cardlytics presently has a consensus price target of $12.75, suggesting a potential upside of 45.05%. Rackspace Technology has a consensus price target of $2.31, suggesting a potential upside of 9.01%. Given Cardlytics' stronger consensus rating and higher probable upside, research analysts clearly believe Cardlytics is more favorable than Rackspace Technology.
Cardlytics has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Comparatively, Rackspace Technology has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500.
Cardlytics received 174 more outperform votes than Rackspace Technology when rated by MarketBeat users. Likewise, 58.20% of users gave Cardlytics an outperform vote while only 46.94% of users gave Rackspace Technology an outperform vote.
Rackspace Technology has a net margin of -29.99% compared to Cardlytics' net margin of -55.23%. Rackspace Technology's return on equity of -10.18% beat Cardlytics' return on equity.
68.1% of Cardlytics shares are held by institutional investors. Comparatively, 82.5% of Rackspace Technology shares are held by institutional investors. 4.4% of Cardlytics shares are held by insiders. Comparatively, 1.0% of Rackspace Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Cardlytics beats Rackspace Technology on 10 of the 18 factors compared between the two stocks.
Get Cardlytics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardlytics Competitors List
Related Companies and Tools
